MH, CCD and CPVT are among the most studied clinical presentations of RyR dysfunction, and the elucidation of the precise molecular mechanisms affected by this dysfunction is advancing with great strides. The gene discussed is RYR2; the disease is catecholaminergic polymorphic ventricular tachycardia.